Efficacy and safety of novel fixed dose combination of vilanterol, glycopyrronium, and fluticasone furoate dry powder inhaler: A phase 3, randomized, non-inferiority trial compared with fixed dose combination of indacaterol,
用户pPhx_RiVhsBE
1个月前
50
10
已完结
1. 系统已在2025-10-16 15:14:26对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.rmed.2025.108293
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0954611125003567
其他信息:
出版社: Elsevier BV
作者: Chintan Patel; Vaishal Sheth; Ravi Koppula; Avadhesh Kumar; Amit S. Bhate; Diptikant Sahoo; Manish Kumar Jain; Asish Mondal; Deven Parmar; Kevinkumar Kansagra; Rahul Shrivastava; Hardik Pathak
